Spots Global Cancer Trial Database for Cladribine Combined With G-CSF and Cytarabine as a Salvage Treatment in R/R ALL
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Cladribine Combined With G-CSF and Cytarabine as a Salvage Treatment in R/R ALL
Official Title: Cladribine Combined With G-CSF and Cytarabine as a Salvage Treatment in Refractory/Relapsed Acute Lymphoblastic Leukemia
Study ID: NCT05578378
Conditions
Study Description
Brief Summary: To explore the efficiency and safety of CLAG regimen in R/R ALL
Detailed Description: R/R Acute Lymphoblastic Leukemia has poor response to second-line chemotherapy.Here,we want to explore efficiency and safety of CLAG regimen in R/R ALL.
Keywords
Eligibility
Minimum Age: 14 Years
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
Contact Details
Name: Yue Han, MD/PhD
Affiliation: Study Principle investigator
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
